Mostrar el registro sencillo del ítem

dc.contributor.authorGarcía del Pino Castro, Isabel
dc.contributor.authorBauça, Josep M
dc.contributor.authorGómez, Carolina
dc.contributor.authorCaballero, Andrea
dc.contributor.authorLlopis, María Antonia
dc.contributor.authorIbarz, Mercedes
dc.contributor.authorMartínez, Débora
dc.contributor.authorVentura, Montserrat
dc.contributor.authorMarzana, Itziar
dc.contributor.authorPuente, Juan J
dc.contributor.authorSegovia, Marta
dc.contributor.authorSalas, Paloma
dc.contributor.authorGómez-Rioja, Rubén
dc.date.accessioned2022-03-16T08:38:20Z
dc.date.available2022-03-16T08:38:20Z
dc.date.issued2020
dc.identifier.issn1330-0962
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pubmed/31839724es
dc.identifier.urihttp://hdl.handle.net/20.500.11940/16268
dc.description.abstractIntroduction: Diabetes mellitus (DM) is one of the most prevalent diseases worldwide. The objective of this study was to find out under what preanalytical conditions routine and diagnostic glucose tests are performed across Spanish laboratories; and also what criteria are used for DM diagnosis. Materials and methods: An online survey was performed by the Commission on Quality Assurance in the Extra-Analytical Phase of the Spanish Society of Laboratory Medicine (SEQC-ML). Access to the questionnaire was available on the home page of the SEQC-ML website during the period April-July 2018. Data analysis was conducted with the IBM SPSS((c)) Statistics (version 20.0) program. Results: A total of 96 valid surveys were obtained. Most laboratories were in public ownership, serving hospital and primary care patients, with high and medium workloads, and a predominance of mixed routine-urgent glucose testing. Serum tubes were the most used for routine glucose analysis (92%) and DM diagnosis (54%); followed by lithium-heparin plasma tubes (62%), intended primarily for urgent glucose testing; point-of-care testing devices were used by 37%; and plasma tubes with a glycolysis inhibitor, mainly sodium fluoride, by 19%. Laboratories used the cut-off values and criteria recognized worldwide for DM diagnosis in adults and glucose-impaired tolerance, but diverged in terms of fasting plasma glucose and gestational DM criteria. Conclusion: Preanalytical processing of routine and DM diagnostic glucose testing in Spain does not allow a significant, non-quantified influence of glycolysis on the results to be ruled out. Possible adverse consequences include a delay in diagnosis and possible under-treatment.en
dc.rightsAtribución 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.meshHumans*
dc.subject.meshBlood Glucose*
dc.subject.meshGlycolysis*
dc.subject.meshDiabetes Mellitus*
dc.subject.meshGlucose*
dc.subject.meshBlood Specimen Collection*
dc.titlePreanalytical issues related to routine and diagnostic glucose tests: Results from a survey in Spainen
dc.typeJournal Articlees
dc.authorsophosGarcía-Del-Pino, Isabel;Bauça, Josep M;Gómez, Carolina;Caballero, Andrea;Llopis, María Antonia;Ibarz, Mercedes;Martínez, Débora;Ventura, Montserrat;Marzana, Itziar;Puente, Juan J;Segovia, Marta;Salas, Paloma;Gómez-Rioja, Rubén
dc.identifier.doi10.11613/BM.2020.010704
dc.identifier.pmid31839724
dc.identifier.sophos36134
dc.issue.number1es
dc.journal.titleBiochemia Medicaes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario de A Coruña::Análise clínicoses
dc.relation.publisherversionhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904967/pdf/bm-30-1-010704.pdfes
dc.rights.accessRightsopenAccess
dc.subject.decsextracción de muestras sanguíneas*
dc.subject.decsglucosa*
dc.subject.decsglicólisis*
dc.subject.decsglucosa sanguínea*
dc.subject.decshumanos*
dc.subject.decsdiabetes mellitus*
dc.subject.keywordCHUACes
dc.typefidesArtículo Originales
dc.typesophosArtículo Originales
dc.volume.number30es


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional